Sas, S <br/><br/>
Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.  [electronic resource] 

 -  Cancer gene therapy  Oct 2008 
 - 655-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5500 
<br/><br/><label>Standard No.: </label>10.1038/cgt.2008.18  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Antibody Formation--immunology<br/>Cancer Vaccines--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Dendritic Cells--immunology<br/>Enzyme-Linked Immunosorbent Assay<br/>Flow Cytometry<br/>Genes, erbB-2--genetics<br/>Genetic Vectors--genetics<br/>Male<br/>Mammary Neoplasms, Animal--genetics<br/>Mice<br/>Mice, Transgenic<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>T-Lymphocytes, Cytotoxic--immunology